Vanderbilt-Ingram Cancer Center SPORE in Gastrointestinal Cancer
- Institution
- Vanderbilt University Medical Center, TN
- Principal investigator
- Robert J. Coffey
- Funding
- $2.4M
- Duration
- 2019–2030
Moonbase score
Still being scored
Abstract
PROJECT SUMMARY/ABSTRACT: Overall This application is an A1 submission of the Vanderbilt-Ingram Cancer Center Gastrointestinal SPORE, which will focus on colorectal cancer, the second leading cause of cancer-related deaths in the United States. Our potential for success is high based on 1) productivity during the previous cycle of the GI SPORE, 2) exceedingly strong institutional support, 3) recruitment of talented investigators to the field of GI cancer through career enhancement and developmental research funding, 4) access to unparalleled resources for drug discovery and ex vivo models, 5) a blend of young and seasoned clinical investigators and basic scientists working together in a highly collegial environment, 6) a committed group of patient advocates now organized into a patient advocacy council and 7) multiple inter-SPORE, pharmaceutical, national and international horizontal and vertical collaborations. We narrowly missed being funded on our A0 submission and have been provided interim funding by NCI. We propose three projects and four supporting cores.
LOADING MOONBASE SCORE
Questions for Vanderbilt University Medical Center
Answered by the team behind this research.
No questions yet. Sign in to ask the first one
Related grants
Same researchers, same institution, same topic, scored first.
- NIH · Vanderbilt University Medical CenterNot yet scored
Shaping the Microenvironment by DPEP1 Facilitates Adenoma Progression
Robert J. Coffey · $281K · 2022–2027
- NIH · Vanderbilt University Medical CenterNot yet scored
Administrative Core
Robert J. Coffey · $262K · 2019–2030
- NIH · Vanderbilt University Medical CenterNot yet scored
Project 1: Overcoming Immune Exclusion in Microsatellite Stable Colorectal Cancer
Robert J. Coffey · $382K · 2019–2030